Patent · US Active

Inherently radiopaque polymeric products for embolotherapy

US10206946B2 · kind B2 · utility

1Cited by

44References

23Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Donald K. Brandom · Davis, US
Eric Schmid · San Diego, US
Joan Zeltinger · Encinitas, US
Durgadas Bolikal · Edison, US
Joachim B. Kohn · South Plainfield, US

Key dates

Filing date	Sep 25, 2017
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Sep 25, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Preferred embodiments relate to compositions of inherently radiopaque, biocompatible, bioresorbable polymeric particles and methods of using them for embolizing a body lumen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.